PTC Therapeutics PTCT Product — Deferred Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's product — deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's product — deferred revenue?
- PTC Therapeutics (PTCT) reported product — deferred revenue of $0 in Q1 2026.
- What does product — deferred revenue mean?
- This represents the obligation to transfer goods or services to a customer for which the company has already received consideration or for which an amount of consideration is due. It reflects deferred revenue or performance obligations that have not yet been satisfied under existing contracts. Monitoring this balance provides insight into future revenue recognition potential and customer commitment levels.